Abstract
Lamellar, cubic and hexagonal mesophases are some of the most common lyotropic liquid crystal systems, and have attracted much research attention because of their distinctive structures and physicochemical properties. Polar lipids and surfactants exhibit a range of phase behavior in an aqueous environment, depending on the composition of the lipids and surfactants. These characteristics have been investigated for a variety of applications in drug delivery, and lyotropic liquid crystal systems have potential as drug carriers for small molecules, peptides, and proteins. In this article we provide an overview of recent advances in the state of the art, including methods of preparation and applications in drug delivery. The scope and limitations of lyotropic liquid crystals for drug delivery are discussed, and future research perspectives are identified.
Similar content being viewed by others
References
Aeinleng N, Songkro S, Noipha K, Srichana T (2012) Physicochemical performances of indomethacin in cholesteryl cetyl carbonate liquid crystal as a transdermal dosage. AAPS PharmSciTech 13:513–521
Ahuja M, Dhake AS, Sharma SK, Majumdar DK (2008) Topical ocular delivery of NSAIDs. AAPS J 10:229–241
Amar-Yuli I, Wachtel E, Shoshan EB, Danino D, Aserin A, Garti N (2007) Hexosome and hexagonal phases mediated by hydration and polymeric stabilizer. Langmuir 23:3637–3645
Amar-Yuli I, Libster D, Aserin A, Garti N (2009) Solubilization of food bioactives within lyotropic liquid crystalline mesophases. Curr Opin Colloid Interface Sci 14:21–32
Angelov B, Angelova A, Vainio U, Garamus VM, Lesieur S, Willumeit R, Couvreur P (2009) Long-living intermediates during a lamellar to a diamond-cubic lipid phase transition: a small-angle X-ray scattering investigation. Langmuir 25:3734–3742
Bitan-Cherbakovsky L, Libster D, Aserin A, Garti N (2011) Complex dendrimer–lyotropic liquid crystalline systems: structural behavior and interactions. J Phys Chem B 115:11984–11992
Boyd BJ, Whittaker DV, Khoo SM, Davey G (2006a) Hexosomes formed from glycerate surfactants-formulation as a colloidal carrier for irinotecan. Int J Pharm 318:154–162
Boyd BJ, Whittaker DV, Khoo S-M, Davey G (2006b) Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm 309:218–226
Boyd BJ, Khoo SM, Whittaker DV, Davey G, Porter CJ (2007) A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. Int J Pharm 340:52–60
Boyd BJ, Dong Y-D, Rades T (2009) Nonlamellar liquid crystalline nanostructured particles: advances in materials and structure determination. J Liposome Res 19:12–28
Cervin C, Vandoolaeghe P, Nistor C, Tiberg F, Johnsson M (2009) A combined in vitro and in vivo study on the interactions between somatostatin and lipid-based liquid crystalline drug carriers and bilayers. Eur J Pharm Sci 36:377–385
Charman WN, Rogge MC, Boddy AW, Berger BM (1993) Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J Clin Pharmacol 33:381–386
Chong JY, Mulet X, Waddington LJ, Boyd BJ, Drummond CJ (2012) High-throughput discovery of novel steric stabilizers for cubic lyotropic liquid crystal nanoparticle dispersions. Langmuir 28:9223–9232
Chung H, Kim JS, Um J, Kwon I, Jeong S (2002) Self-assembled “nanocubicle” as a carrier for peroral insulin delivery. Diabetologia 45:448–451
Cohen-Avrahami M, Libster D, Aserin A, Garti N (2012) Penetratin-induced transdermal delivery from HII mesophases of sodium diclofenac. J Control Release 159:419–428
Dalm V, Hofland L, Lamberts S (2008) Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field. Mol Cell Endocrinol 286:262–277
Dima L, Abraham A, Ellen W, Gil S, Garti N (2007) An HII liquid crystal-based delivery system for cyclosporin A: physical characterization. J Colloid Interface Sci 308:514–524
Dong YD, Larson I, Barnes TJ, Prestidge CA, Boyd BJ (2011) Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds. ACS Appl Mater Interfaces 3:1771–1780
Dong YD, Larson I, Barnes TJ, Prestidge CA, Allen S, Chen X, Roberts CJ, Boyd BJ (2012) Understanding the interfacial properties of nanostructured liquid crystalline materials for surface-specific delivery applications. Langmuir 28:13485–13495
Drummond CJ, Fong C (1999) Surfactant self-assembly objects as novel drug delivery vehicles. Curr Opin Colloid Interface Sci 4:449–456
Engström S, Engström L (1992) Phase behaviour of the lidocaine-monoolein-water system. Int J Pharm 79:113–122
Engström S, Lindahl L, Wallin R, Engblom J (1992) A study of polar lipid drug systems undergoing a thermoreversible lamellar-to-cubic phase transition. Int J Pharm 86:137–145
Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C (2005) Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 22:2163–2173
Fong WK, Hanley T, Boyd BJ (2009) Stimuli responsive liquid crystals provide ‘on-demand’ drug delivery in vitro and in vivo. J Control Release 135:218–226
Fong WK, Hanley TL, Thierry B, Kirby N, Waddington LJ, Boyd BJ (2012) Controlling the nanostructure of gold nanorod-lyotropic liquid-crystalline hybrid materials using near-infrared laser irradiation. Langmuir 28:14450–14460
Fraser SJ, Mulet X, Hawley A, Separovic F, Polyzos A (2013) Controlling nanostructure and lattice parameter of the inverse bicontinuous cubic phases in functionalised phytantriol dispersions. J Colloid Interf Sci 408:117–124
Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X, Gan Y (2010) Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm 396:179–187
Garg G, Saraf S, Saraf S (2007) Cubosomes: an overview. Biol Pharm Bull 30:350–353
Garti N, Hoshen G, Aserin A (2012) Lipolysis and structure controlled drug release from reversed hexagonal mesophase. Colloid Surf B 94:36–43
Geraghty PB, Attwood D, Collett JH, Dandiker Y (1996) The in vitro release of some antimuscarinic drugs from monoolein/water lyotropic liquid crystalline gels. Pharm Res 13:1265–1271
Gong X, Moghaddam MJ, Sagnella SM, Conn CE, Danon SJ, Waddington LJ, Drummond CJ (2011) Lyotropic liquid crystalline self-assembly material behavior and nanoparticulate dispersions of a phytanyl pro-drug analogue of capecitabine-A chemotherapy agent. ACS Appl Mater Interfaces 3:1552–1561
Guillot S, Salentinig S, Chemelli A, Sagalowicz L, Leser ME, Glatter O (2010) Influence of the stabilizer concentration on the internal liquid crystalline order and the size of oil-loaded monolinolein-based dispersions. Langmuir 26:6222–6229
Guo C, Wang J, Cao F, Lee RJ, Zhai G (2010) Lyotropic liquid crystal systems in drug delivery. Drug Discov Today 15:1032–1040
Gustafsson J, Ljusberg-Wahren H, Almgren M, Larsson K (1997) Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir 13:6964–6971
Han S, Shen JQ, Gan Y, Geng HM, Zhang XX, Zhu CL, Gan L (2010) Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability. Acta Pharmacol Sin 31:990–998
Hirlekar R, Jain S, Patel M, Garse H, Kadam V (2010) Hexosomes: a novel drug delivery system. Curr Drug Deliv 7:28–35
Israelachvili JN, Mitchell DJ, Ninham BW (1976) Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers. J Chem Soc Faraday Trans 2(72):1525–1568
Jain V, Swarnakar NK, Mishra PR, Verma A, Kaul A, Mishra AK, Jain NK (2012) Paclitaxel loaded PEGylated glyceryl monooleate based nanoparticulate carriers in chemotherapy. Biomaterials 33:7206–7220
Jin X, Zhang ZH, Li SL, Sun E, Tan XB, Song J, Jia XB (2013) A nanostructured liquid crystalline formulation of 20 (S)-protopanaxadiol with improved oral absorption. Fitoterapia 84:64–71
Kaasgaard T, Drummond CJ (2006) Ordered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solvent. Phys Chem Chem Phys 8:4957–4975
Ki MH, Lim JL, Ko JY, Park SH, Kim JE, Cho HJ, Park ES, Kim DD (2014) A new injectable liquid crystal system for one month delivery of leuprolide. J Control Release 185:62–70
Kuntsche J, Horst JC, Bunjes H (2011) Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems. Int J Pharm 417:120–137
Lai J, Chen J, Lu Y, Sun J, Hu F, Yin Z, Wu W (2009) Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems. I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. AAPS PharmSciTech 10:960–966
Lapteva M, Kalia YN (2013) Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery. Expert Opin Drug Deliv 10:1043–1059
Larsson K (1999) Colloidal dispersions of ordered lipid-water phases. J Dispers Sci Technol 20:27–34
Lee KW, Nguyen TH, Hanley T, Boyd BJ (2009) Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. Int J Pharm 365:190–199
Leesajakul W, Nakano M, Taniguchi A, Handa T (2004) Interaction of cubosomes with plasma components resulting in the destabilization of cubosomes in plasma. Colloid Surf B 34:253–258
Libster D, Aserin A, Garti N (2011) Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications. J Colloid Interf Sci 356:375–386
Lopes LB, Ferreira DA, De Paula D, Garcia MTJ, Thomazini JA, Fantini MC, Bentley MVL (2006) Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm Res 23:1332–1342
Lynch ML, Ofori-Boateng A, Hippe A, Kochvar K, Spicer PT (2003) Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants. J Colloid Interf Sci 260:404–413
Malmsten M (2007) Phase transformations in self-assembly systems for drug delivery applications. J Dispers Sci Technol 28:63–72
Negrini R, Mezzenga R (2011) pH-responsive lyotropic liquid crystals for controlled drug delivery. Langmuir 27:5296–5303
Negrini R, Mezzenga R (2012) Diffusion, molecular separation, and drug delivery from lipid mesophases with tunable water channels. Langmuir 28:16455–16462
Nemanic MK, Elias PM (1980) In situ precipitation: a novel cytochemical technique for visualization of permeability pathways in mammalian stratum corneum. J Histochem Cytochem 28:573–578
Nguyen TH, Hanley T, Porter CJ, Boyd BJ (2011) Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. J Control Release 153:180–186
Nielsen LS, Schubert L, Hansen J (1998) Bioadhesive drug delivery systems: I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate. Eur J Pharm Sci 6:231–239
Norling T, Lading P, Engstrom S, Larsson K, Krog N, Nissen SS (1992) Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. J Clin Periodontol 19:687–692
Nylander T, Mattisson C, Razumas V, Miezis Y, Håkansson B (1996) A study of entrapped enzyme stability and substrate diffusion in a monoglyceride-based cubic liquid crystalline phase. Colloid Surf A 114:311–320
Park ES, Maniar M, Shah JC (1998) Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release. J Control Release 52:179–189
Quinn PJ (2012) The effect of tocopherol on the structure and permeability of phosphatidylcholine liposomes. J Control Release 160:158–163
Rattanapak T, Birchall J, Young K, Ishii M, Meglinski I, Rades T, Hook S (2013) Transcutaneous immunization using microneedles and cubosomes: mechanistic investigations using optical coherence tomography and two-photon microscopy. J Control Release 172:894–903
Rizwan S, Dong YD, Boyd B, Rades T, Hook S (2007) Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron 38:478–485
Rizwan SB, Boyd BJ, Rades T, Hook S (2010) Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins. Expert Opin Drug Deliv 7:1133–1144
Rizwan S, Mcburney W, Young K, Hanley T, Boyd B, Rades T, Hook S (2013) Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses. J Control Release 165:16–21
Rossetti FC, Fantini MC, Carollo ARH, Tedesco AC, Lopes Badra Bentley MV (2011) Analysis of liquid crystalline nanoparticles by small angle X-ray diffraction: evaluation of drug and pharmaceutical additives influence on the internal structure. J Pharm Sci 100:2849–2857
Sadhale Y, Shah JC (1998) Glyceryl monooleate cubic phase gel as chemical stability enhancer of cefazolin and cefuroxime. Pharm Dev Technol 3:549–556
Salentinig S, Yaghmur A, Guillot S, Glatter O (2008) Preparation of highly concentrated nanostructured dispersions of controlled size. J Colloid Interface Sci 326:211–220
Spicer P (2005) Cubosome processing: industrial nanoparticle technology development. Chem Eng Res Des 83:1283–1286
Swarnakar NK, Jain V, Dubey V, Mishra D, Jain N (2007) Enhanced oromucosal delivery of progesterone via hexosomes. Pharm Res 24:2223–2230
Wörle G, Siekmann B, Koch MH, Bunjes H (2006) Transformation of vesicular into cubic nanoparticles by autoclaving of aqueous monoolein/poloxamer dispersions. Eur J Pharm Sci 27:44–53
Wörle G, Drechsler M, Koch M, Siekmann B, Westesen K, Bunjes H (2007) Influence of composition and preparation parameters on the properties of aqueous monoolein dispersions. Int J Pharm 329:150–157
Yamada K, Yamashita J, Todo H, Miyamoto K, Hashimoto S, Tokudome Y, Hashimoto F, Sugibayashi K (2011) Preparation and evaluation of liquid-crystal formulations with skin-permeation-enhancing abilities for entrapped drugs. J Oleo Sci 60:31–40
Zhai J, Waddington L, Wooster TJ, Aguilar MI, Boyd BJ (2011) Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles. Langmuir 27:14757–14766
Zhen G, Hinton TM, Muir BW, Shi S, Tizard M, Mclean KM, Hartley PG, Gunatillake P (2012) Glycerol monooleate-based nanocarriers for siRNA delivery in vitro. Mol Pharm 9:2450–2457
Acknowledgments
This article does not contain any studies with human and animal subjects performed by any of the authors. All authors (D.-H. Kim, A. Jahn, S.-J. Cho, J. S. Kim, M.-H Ki, and D.-D. Kim) declare that they have no conflict of interest. This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean government (MSIP) (No. 2009-0083533) and the MarineBio Research Program (NRF-C1ABA001-2011-0018561).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, DH., Jahn, A., Cho, SJ. et al. Lyotropic liquid crystal systems in drug delivery: a review. Journal of Pharmaceutical Investigation 45, 1–11 (2015). https://doi.org/10.1007/s40005-014-0165-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-014-0165-9